Cargando…
Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs
Recently, research has focused on targeting the oxidative and metabolic vulnerabilities in cancer cells. Natural compounds like curcumin that target such susceptibilities have failed further clinical advancements due to the poor stability and bioavailability as well as the need of high effective dos...
Autores principales: | Pignanelli, Christopher, Ma, Dennis, Noel, Megan, Ropat, Jesse, Mansour, Fadi, Curran, Colin, Pupulin, Simon, Larocque, Kristen, Wu, Jianzhang, Liang, Guang, Wang, Yi, Pandey, Siyaram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430918/ https://www.ncbi.nlm.nih.gov/pubmed/28439094 http://dx.doi.org/10.1038/s41598-017-01230-4 |
Ejemplares similares
-
Evaluating the Anti-cancer Efficacy of a Synthetic Curcumin Analog on Human Melanoma Cells and Its Interaction with Standard Chemotherapeutics
por: Parashar, Krishan, et al.
Publicado: (2019) -
Cymbopogon citratus and Camellia sinensis extracts selectively induce apoptosis in cancer cells and reduce growth of lymphoma xenografts in vivo
por: Philion, Cory, et al.
Publicado: (2017) -
Cancer Cell Mitochondria Targeting by Pancratistatin Analogs is Dependent on Functional Complex II and III
por: Ma, Dennis, et al.
Publicado: (2017) -
Corrigendum: Cancer Cell Mitochondria Targeting by Pancratistatin Analogs is Dependent on Functional Complex II and III
por: Ma, Dennis, et al.
Publicado: (2018) -
Exploiting Mitochondrial Vulnerabilities to Trigger Apoptosis Selectively in Cancer Cells
por: Nguyen, Christopher, et al.
Publicado: (2019)